Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arcus Biosciences, Inc. (RCUS) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arcus Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1724521.
Total stock buying since 2018: $581,531,970.
Total stock sales since 2018: $10,939,877.
Total stock option exercises since 2018: $279,650.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 1,363,636 | $14,999,996 | 0 | $0 | 0 | $0 |
| 2024 | 15,238,095 | $319,999,995 | 121,194 | $2,372,647 | 0 | $0 |
| 2023 | 1,010,000 | $19,452,600 | 126,968 | $2,454,384 | 0 | $0 |
| 2022 | 0 | $0 | 51,635 | $1,264,750 | 0 | $0 |
| 2021 | 5,674,133 | $221,046,652 | 131,114 | $4,781,729 | 0 | $0 |
| 2020 | 48,905 | $1,111,093 | 2,117 | $66,367 | 35,000 | $279,650 |
| 2019 | 153,678 | $1,233,335 | 0 | $0 | 0 | $0 |
| 2018 | 258,449 | $3,688,299 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-02 | 1,363,636 | $14,999,996 | 0 | $0 | 0 | $0 |
| 2024-12 | 0 | $0 | 201 | $3,079 | 0 | $0 |
| 2024-08 | 0 | $0 | 1,357 | $20,314 | 0 | $0 |
| 2024-03 | 0 | $0 | 25,000 | $447,895 | 0 | $0 |
| 2024-02 | 0 | $0 | 85,657 | $1,721,152 | 0 | $0 |
| 2024-01 | 15,238,095 | $319,999,995 | 8,979 | $180,207 | 0 | $0 |
| 2023-12 | 0 | $0 | 21,803 | $386,427 | 0 | $0 |
| 2023-09 | 0 | $0 | 21,369 | $427,166 | 0 | $0 |
| 2023-07 | 0 | $0 | 46,018 | $932,027 | 0 | $0 |
| 2023-06 | 1,010,000 | $19,452,600 | 29,049 | $562,030 | 0 | $0 |
| 2023-03 | 0 | $0 | 8,729 | $146,734 | 0 | $0 |
| 2022-09 | 0 | $0 | 12,677 | $333,151 | 0 | $0 |
| 2022-06 | 0 | $0 | 29,341 | $627,510 | 0 | $0 |
| 2022-03 | 0 | $0 | 9,617 | $304,089 | 0 | $0 |
| 2021-12 | 0 | $0 | 56,930 | $2,334,557 | 0 | $0 |
| 2021-09 | 0 | $0 | 47,500 | $1,687,356 | 0 | $0 |
| 2021-06 | 0 | $0 | 15,896 | $381,914 | 0 | $0 |
| 2021-04 | 4,133 | $129,652 | 0 | $0 | 0 | $0 |
| 2021-03 | 20,000 | $567,000 | 10,788 | $377,902 | 0 | $0 |
| 2021-01 | 5,650,000 | $220,350,000 | 0 | $0 | 0 | $0 |
| 2020-12 | 0 | $0 | 2,117 | $66,367 | 0 | $0 |
| 2020-09 | 5,000 | $107,850 | 0 | $0 | 0 | $0 |
| 2020-08 | 43,705 | $999,299 | 0 | $0 | 0 | $0 |
| 2020-07 | 200 | $3,944 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-18 | Gilead Sciences, Inc. (10% Owner) | Buy | 1,363,636 | 11.00 | 14,999,996 |
| 2024-12-02 | Azoy Alexander (Chief Accounting Officer) | Sale | 201 | 15.32 | 3,079 |
| 2024-08-13 | Azoy Alexander (Chief Accounting Officer) | Sale | 1,357 | 14.97 | 20,314 |
| 2024-03-27 | Jarrett Jennifer (Chief Operating Officer) | Sale | 11,551 | 17.55 | 202,720 |
| 2024-03-18 | Jarrett Jennifer (Chief Operating Officer) | Sale | 13,449 | 18.23 | 245,175 |
| 2024-02-27 | Jarrett Jennifer (Chief Operating Officer) | Sale | 34,070 | 20.11 | 685,147 |
| 2024-02-27 | Jaen Juan C. (President) | Sale | 23,132 | 20.10 | 464,953 |
| 2024-02-26 | Jarrett Jennifer (Chief Operating Officer) | Sale | 24,555 | 20.07 | 492,818 |
| 2024-02-26 | Jaen Juan C. (President) | Sale | 3,900 | 20.06 | 78,234 |
| 2024-01-29 | Gilead Sciences, Inc. | Buy | 15,238,095 | 21.00 | 319,999,995 |
| 2024-01-02 | Goeltz Ii Robert C. (Chief Financial Officer) | Sale | 2,004 | 20.00 | 40,080 |
| 2024-01-02 | Jaen Juan C. (President) | Sale | 6,975 | 20.09 | 140,127 |
| 2023-12-22 | Jarrett Jennifer (Chief Operating Officer) | Sale | 21,521 | 17.76 | 382,212 |
| 2023-12-01 | Azoy Alexander (Chief Accounting Officer) | Sale | 282 | 14.95 | 4,215 |
| 2023-09-22 | Jarrett Jennifer (Chief Operating Officer) | Sale | 21,369 | 19.99 | 427,166 |
| 2023-07-28 | Jarrett Jennifer (Chief Operating Officer) | Sale | 45,000 | 20.25 | 911,250 |
| 2023-07-03 | Azoy Alexander (Chief Accounting Officer) | Sale | 1,018 | 20.41 | 20,777 |
| 2023-06-28 | Gilead Sciences, Inc. | Buy | 1,010,000 | 19.26 | 19,452,600 |
| 2023-06-22 | Jarrett Jennifer (Chief Operating Officer) | Sale | 12,437 | 19.12 | 237,795 |
| 2023-06-16 | Jarrett Jennifer (Chief Operating Officer) | Sale | 12,563 | 19.35 | 243,094 |
| 2023-06-07 | Goeltz Ii Robert C. (Chief Financial Officer) | Sale | 4,049 | 20.04 | 81,141 |
| 2023-03-16 | Jarrett Jennifer (Chief Operating Officer) | Sale | 8,729 | 16.81 | 146,734 |
| 2022-09-16 | Jarrett Jennifer (Chief Operating Officer) | Sale | 12,677 | 26.28 | 333,151 |
| 2022-06-17 | Tang Carolyn C. (General Counsel) | Sale | 1,522 | 22.00 | 33,484 |
| 2022-06-17 | Jarrett Jennifer (Chief Operating Officer) | Sale | 6,614 | 22.00 | 145,508 |
| 2022-06-17 | Jaen Juan C. (President) | Sale | 2,537 | 22.00 | 55,814 |
| 2022-06-17 | Rosen Terry J (Chief Executive Officer) | Sale | 4,613 | 22.00 | 101,486 |
| 2022-06-16 | Tang Carolyn C. (General Counsel) | Sale | 1,400 | 20.72 | 29,008 |
| 2022-06-16 | Jarrett Jennifer (Chief Operating Officer) | Sale | 6,081 | 20.72 | 125,998 |
| 2022-06-16 | Jaen Juan C. (President) | Sale | 2,333 | 20.72 | 48,339 |
| 2022-06-16 | Rosen Terry J (Chief Executive Officer) | Sale | 4,241 | 20.72 | 87,873 |
| 2022-03-16 | Jarrett Jennifer (Chief Operating Officer) | Sale | 9,617 | 31.62 | 304,089 |
| 2021-12-20 | Jarrett Jennifer (Chief Operating Officer) | Sale | 34,822 | 41.60 | 1,448,595 |
| 2021-12-17 | Tang Carolyn C. (General Counsel) | Sale | 622 | 40.11 | 24,950 |
| 2021-12-17 | Jarrett Jennifer (Chief Operating Officer) | Sale | 7,118 | 40.11 | 285,531 |
| 2021-12-17 | Goeltz Ii Robert C. (Chief Financial Officer) | Sale | 621 | 40.11 | 24,910 |
| 2021-12-17 | Jaen Juan C. (President) | Sale | 1,108 | 40.11 | 44,446 |
| 2021-12-17 | Rosen Terry J (Chief Executive Officer) | Sale | 2,943 | 40.11 | 118,055 |
| 2021-12-16 | Tang Carolyn C. (General Counsel) | Sale | 487 | 40.02 | 19,491 |
| 2021-12-16 | Jarrett Jennifer (Chief Operating Officer) | Sale | 5,560 | 40.02 | 222,533 |
| 2021-12-16 | Goeltz Ii Robert C. (Chief Financial Officer) | Sale | 485 | 40.02 | 19,411 |
| 2021-12-16 | Jaen Juan C. (President) | Sale | 865 | 40.02 | 34,620 |
| 2021-12-16 | Rosen Terry J (Chief Executive Officer) | Sale | 2,299 | 40.02 | 92,015 |
| 2021-09-21 | Jarrett Jennifer (Chief Operating Officer) | Sale | 16,866 | 35.74 | 602,790 |
| 2021-09-20 | Jarrett Jennifer (Chief Operating Officer) | Sale | 30,634 | 35.40 | 1,084,566 |
| 2021-06-17 | Grossman William (Chief Medical Officer) | Sale | 3,891 | 23.68 | 92,138 |
| 2021-06-17 | Jarrett Jennifer (Chief Operating Officer) | Sale | 4,863 | 23.68 | 115,155 |
| 2021-06-16 | Grossman William (Chief Medical Officer) | Sale | 3,174 | 24.45 | 77,604 |
| 2021-06-16 | Jarrett Jennifer (Chief Operating Officer) | Sale | 3,968 | 24.45 | 97,017 |
| 2021-04-23 | Kaneko Yasunori | Buy | 4,133 | 31.37 | 129,652 |
| 2021-03-31 | Falberg Kathryn E (Director) | Buy | 20,000 | 28.35 | 567,000 |
| 2021-03-16 | Grossman William (Chief Medical Officer) | Sale | 2,127 | 35.03 | 74,508 |
| 2021-03-16 | Jarrett Jennifer (Chief Operating Officer) | Sale | 8,661 | 35.03 | 303,394 |
| 2021-01-31 | Gilead Sciences Inc (10% Owner) | Buy | 5,650,000 | 39.00 | 220,350,000 |
| 2020-12-16 | Grossman William (Chief Medical Officer) | Sale | 2,117 | 31.35 | 66,367 |
| 2020-09-09 | Goeltz Ii Robert C. (Chief Financial Officer) | Buy | 5,000 | 21.57 | 107,850 |
| 2020-08-10 | Rosen Terry J (Chief Executive Officer) | Buy | 32,050 | 23.38 | 749,393 |
| 2020-08-07 | Rosen Terry J (Chief Executive Officer) | Buy | 11,655 | 21.44 | 249,906 |
| 2020-07-31 | Grossman William (Chief Medical Officer) | Buy | 200 | 19.72 | 3,944 |
| 2020-06-05 | Kaneko Yasunori (Director) | Option Ex | 35,000 | 7.99 | 279,650 |
| 2019-10-14 | Grossman William (Chief Medical Officer) | Buy | 300 | 8.00 | 2,400 |
| 2019-10-10 | Grossman William (Chief Medical Officer) | Buy | 100 | 8.00 | 800 |
| 2019-06-28 | Jaen Juan C. (President) | Buy | 4,894 | 7.89 | 38,638 |
| 2019-06-27 | Jaen Juan C. (President) | Buy | 10,106 | 7.44 | 75,218 |
| 2019-06-13 | Falberg Kathryn E (Director) | Buy | 12,935 | 8.52 | 110,154 |
| 2019-06-12 | Falberg Kathryn E (Director) | Buy | 10,000 | 8.49 | 84,930 |
| 2019-06-11 | Falberg Kathryn E (Director) | Buy | 10,000 | 7.90 | 79,000 |
| 2019-06-10 | Falberg Kathryn E (Director) | Buy | 10,000 | 8.25 | 82,500 |
| 2019-06-07 | Falberg Kathryn E (Director) | Buy | 22,065 | 7.99 | 176,299 |
| 2019-06-06 | Rosen Terry J (Chief Executive Officer) | Buy | 2,380 | 7.95 | 18,928 |
| 2019-06-05 | Rosen Terry J (Chief Executive Officer) | Buy | 19,358 | 7.92 | 153,412 |
| 2019-06-04 | Rosen Terry J (Chief Executive Officer) | Buy | 25,770 | 7.75 | 199,820 |
| 2019-06-03 | Jaen Juan C. (President) | Buy | 10,000 | 8.25 | 82,490 |
| 2019-06-03 | Rosen Terry J (Chief Executive Officer) | Buy | 15,770 | 8.16 | 128,746 |
| 2018-11-13 | Jaen Juan C. (President) | Buy | 10,000 | 11.80 | 118,040 |
| 2018-08-28 | Rosen Terry J (Chief Executive Officer) | Buy | 10,650 | 15.48 | 164,840 |
| 2018-08-27 | Rosen Terry J (Chief Executive Officer) | Buy | 7,957 | 14.70 | 116,983 |
| 2018-08-24 | Rosen Terry J (Chief Executive Officer) | Buy | 4,954 | 13.40 | 66,363 |
| 2018-08-23 | Rosen Terry J (Chief Executive Officer) | Buy | 2,133 | 13.50 | 28,799 |
| 2018-08-22 | Rosen Terry J (Chief Executive Officer) | Buy | 2,202 | 13.52 | 29,777 |
| 2018-08-21 | Rosen Terry J (Chief Executive Officer) | Buy | 2,790 | 13.20 | 36,828 |
| 2018-08-20 | Rosen Terry J (Chief Executive Officer) | Buy | 1,301 | 13.21 | 17,186 |
| 2018-08-17 | Rosen Terry J (Chief Executive Officer) | Buy | 4,800 | 13.27 | 63,715 |
| 2018-08-16 | Rosen Terry J (Chief Executive Officer) | Buy | 8,932 | 12.95 | 115,651 |
| 2018-08-15 | Rosen Terry J (Chief Executive Officer) | Buy | 13,300 | 12.57 | 167,234 |
| 2018-08-14 | Rosen Terry J (Chief Executive Officer) | Buy | 6,169 | 12.36 | 76,236 |
| 2018-08-13 | Jaen Juan C. (President) | Buy | 3,159 | 11.77 | 37,168 |
| 2018-08-13 | Rosen Terry J (Chief Executive Officer) | Buy | 3,279 | 11.75 | 38,534 |
| 2018-08-10 | Jaen Juan C. (President) | Buy | 2,579 | 11.94 | 30,795 |
| 2018-08-10 | Rosen Terry J (Chief Executive Officer) | Buy | 2,550 | 11.94 | 30,449 |
| 2018-08-09 | Jaen Juan C. (President) | Buy | 4,262 | 11.93 | 50,854 |
| 2018-08-09 | Rosen Terry J (Chief Executive Officer) | Buy | 4,100 | 11.92 | 48,867 |
| 2018-03-19 | Jaen Juan C. (President) | Buy | 66,666 | 15.00 | 999,990 |
| 2018-03-19 | Falberg Kathryn E (Director) | Buy | 30,000 | 15.00 | 450,000 |
| 2018-03-19 | Rosen Terry J (Chief Executive Officer) | Buy | 66,666 | 15.00 | 999,990 |
Insider trading activities including stock purchases, stock sales, and option exercises of RCUS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arcus Biosciences, Inc. (symbol RCUS, CIK number 1724521) see the Securities and Exchange Commission (SEC) website.